Asterriquinones could potentially treat neurodegenerative diseases such as Alzheimer’s and Parkinson’s by activating tyrosine kinases (TrkA, TrkB and TrkC) receptors [43,44,45]. This evidence concerns the gene NTRK1 and Parkinson disease.